Top 100 Selling Drugs of 2013 - Medscape
Jan 30, 2014. After aripiprazole, the next best selling drugs in 2013 were Nexium, at $6.1. Rounding out the top 10 in sales were Crestor $5.3 billion. Feb 8, 2016. performance was driven by the key products Abilify Maintena®. For 2016, Lundbeck expects revenue of around DKK 13.8-14.2 billion and. Sep 20, 2016. Abilify — $9.3 Billion Annual Sales. Abilify is owned by Otsuka Group and is prescribed for serious mental illnesses such as severe depression.
Solid sales performance in 2015 and return to profitability in 2016
Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. As of 2013, Abilify had annual sales of US$7 billion. In 2013 BMS. Mar 8, 2015. Abilify is both. It's the 14th most prescribed brand-name medication, and it retails for about $30 a pill. Annual sales are over $7 billion, nearly a. Aug 8, 2017. *”Excluding ABILIFY” in this material represents Net sales excluding ABILIFY and Milestone/Upfront revenue. Net Sales. Net Sales by Market.
ANNUAL REPORT 2015
Mar 31, 2015. Otsuka Holdings Co. Ltd. ANNUAL REPORT 20. 1. 5. *1 Net sales excluding ABILIFY and milestone/upfront revenue. * As a result of the. Abilify aripiprazole patent expiry in the US and 5EU in. annual growth rate CAGR of 2.40% over the. Schizophrenia Drug Sales by Region, 2012–2022.